Eosinophilic gastrointestinal diseases: current perspectives on pathogenesis and management
Open Access
- 7 June 2024
- journal article
- review article
- Published by Open Exploration Publishing
- Vol. 2, 205-218
Abstract
Eosinophilic gastrointestinal diseases (EGIDs) are a group of chronic conditions, characterized by an excessive accumulation of eosinophils in various areas of the mucosal of the gastrointestinal (GI) tract. EGIDs encompass a spectrum of diseases, including eosinophilic esophagitis (EoE), eosinophilic gastritis (EoG), eosinophilic enteritis (EoN), and eosinophilic colitis (EoC), each affecting different segments of the GI tract. The pathogenesis of EGIDs is multifaceted and involves an intricate interplay between genetic predisposition, environmental triggers, and dysregulated immune responses. Although the exact etiology behind EGIDs is not fully understood, it is clear that they are immune-mediated, with eosinophils having a central role in inflammation and tissue damage of GI mucosal. Clinical manifestations depend on the organ that is affected by the disease and on the depth of the eosinophil infiltration of the bowel wall. They range from mild discomfort to severe dysphagia, abdominal pain, malnutrition, and growth failure, particularly in pediatric cases. Regarding EGID management, it is a challenging issue to achieve clinical and histologic remission using pharmacotherapy and dietary elimination. Corticosteroids and proton pump inhibitors can be selected as an effective first-line treatment for certain patients and six-food elimination diet (6-FED) has been proven effective in inducing remission. Furthermore, biologic therapies have emerged as essential tools in controlling eosinophilic-driven inflammation. This review focuses on the complex pathogenesis and treatment of these inflammatory diseases, especially EoE.Keywords
This publication has 65 references indexed in Scilit:
- Eosinophilic EsophagitisJAMA, 2021
- Management of Eosinophilic Esophagitis: Dietary and Nondietary ApproachesNutrition in Clinical Practice, 2020
- AGA institute and the joint task force on allergy-immunology practice parameters clinical guidelines for the management of eosinophilic esophagitisAnnals of Allergy, Asthma & Immunology, 2020
- Eosinophilic gastrointestinal diseases – Pathogenesis, diagnosis, and treatmentAllergology International, 2019
- Eosinophilic esophagitis: novel concepts regarding pathogenesis and clinical manifestationsJournal of Gastroenterology, 2019
- Subcutaneous immunotherapy in patients with eosinophilic esophagitisAnnals of Allergy, Asthma & Immunology, 2019
- Summary of the updated international consensus diagnostic criteria for eosinophilic esophagitisAnnals of Allergy, Asthma & Immunology, 2018
- What Is the Relationship Between Eosinophilic Esophagitis (EoE) and Aeroallergens? Implications for Allergen ImmunotherapyCurrent Allergy and Asthma Reports, 2018
- Eosinophilic Esophagitis in Children: Endoscopic Findings at Diagnosis and Post-interventionCurrent Gastroenterology Reports, 2018
- Pediatric Eosinophilic Esophagitis Endotypes: Are We Closer to Predicting Treatment Response?Clinical Reviews in Allergy & Immunology, 2017